Walleye Capital LLC Vanda Pharmaceuticals Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $300,973 - $399,852	-86,736 Reduced 82.02%	19,018 $78,000
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $514,412 - $697,043	-152,193 Reduced 59.0%	105,754 $446,000
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $185,255 - $284,375	-43,284 Reduced 14.37%	257,947 $1.11 Million
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $83,414 - $98,259	-14,138 Reduced 4.48%	301,231 $1.99 Million
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $1.04 Million - $1.34 Million	168,329 Added 114.48%	315,369 $2.14 Million
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $1.01 Million - $1.61 Million	147,040 New	147,040 $1.09 Million
Q2 2022 Aug 08, 2022	BUY	$9.31 - $11.84 $1.21 Million - $1.54 Million	130,114 Added 203.14%	194,164 $2.12 Million
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $481,740 - $735,498	-44,441 Reduced 40.96%	64,050 $724,000
Q4 2021 Mar 03, 2022	BUY	$15.69 - $21.14 $1.7 Million - $2.29 Million	108,491 New	108,491 $1.7 Million

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.